Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Treasury Shares (2020 - 2025)

PAVmed has reported Treasury Shares over the past 1 years, most recently at $408000.0 for Q4 2022.

  • For Q4 2025, Treasury Shares rose 526.57% year-over-year to $67739.0; the TTM value through Dec 2025 reached $67739.0, up 526.57%, while the annual FY2025 figure was $67739.0, 526.57% up from the prior year.
  • Treasury Shares for Q4 2025 was $67739.0 at PAVmed, down from $2.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $3.9 million in Q2 2024 and troughed at $10811.0 in Q4 2024.
  • A 5-year average of $1.6 million and a median of $1.9 million in 2021 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: tumbled 99.54% in 2024 and later surged 526.57% in 2025.
  • Year by year, Treasury Shares stood at $1.9 million in 2021, then rose by 7.76% to $2.1 million in 2022, then rose by 11.76% to $2.3 million in 2023, then crashed by 99.54% to $10811.0 in 2024, then surged by 526.57% to $67739.0 in 2025.
  • Business Quant data shows Treasury Shares for PAVM at $408000.0 in Q4 2022, $408000.0 in Q3 2022, and $548000.0 in Q2 2022.